Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Catarino, Rosa ^a,b   Vassilakos, Pierre ^c   Bilancioni, Aline ^a   Eynde, Mathieu Vanden ^a   Meyer Hamme, Ulrike ^a   Menoud, Pierre Alain ^d   Guerry, Frédéric ^d   Petignat, Patrick ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

^d Unilabs   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRY SWAB; FEMALE; FTA CARTRIDGE; GENE FREQUENCY; GENOTYPE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; VIRUS DETECTION; WART VIRUS; COMPARATIVE STUDY; DEVICES; GENETICS; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; FEMALE; GENOTYPE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS;

EID: 84955515629     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143644     Document Type: Article

References (23)

1. American Cancer Society. Global Cancer Facts & Figures 2nd Edition. Atlanta: American Cancer Society, 2011.
2. Mayrand M-H, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007; 357 (16):1579-88. PMID: 17942871
3. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst. 2008; 100(7):492-501. doi: 10.1093/jnci/djn065 PMID: 18364502
4. Cox JT. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. J Clin Virol. 2009; 45:S3-S12. doi: 10.1016/S1386-6532(09)70002-2 PMID: 19651367
5. Gök M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010; 340:c1040. doi: 10.1136/bmj.c1040 PMID: 20223872
6. Nobbenhuis MA, Helmerhorst T, Van den Brule A, Rozendaal L, Jaspars L, Voorhorst F, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol. 2002; 55(6):435-9. PMID: 12037026
7. Harper DM, Noll WW, Belloni DR, Cole BF. Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed-Biologic concordance and women's preferences. Am J Obstet Gynecol. 2002; 186(3):365-73. PMID: 11904593
8. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007; 105(2):530-5. PMID: 17335880
9. Ogilvie G, Patrick D, Schulzer M, Sellors J, Petric M, Chambers K, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. STI. 2005; 81(3):207-12.
10. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. The lancet oncology. 2014; 15(2):172-83. doi: 10.1016/S1470-2045(13)70570-9 PMID: 24433684
11. Sherris J, Wittet S, Kleine A, Sellors J, Luciani S, Sankaranarayanan R, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health. 2009; 35(3):147-52. doi: 10.1363/ifpp.35.147.09 PMID: 19805020
12. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360(14):1385-94. doi: 10.1056/NEJMoa0808516 PMID: 19339719
13. De Bie RP, Schmeink CE, Bakkers JM, Snijders PJ, Quint WG, Massuger LF, et al. The indicating FTA elute cartridge: a solid sample carrier to detect high-risk HPV and high-grade cervical lesions. J Mol Diagn. 2011; 13(4):371-6. doi: 10.1016/j.jmoldx.2011.02.003 PMID: 21704269
14. Gustavsson I, Sanner K, Lindell M, Strand A, Olovsson M, Wikström I, et al. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol. 2011; 51(4):255-8. doi: 10.1016/j.jcv.2011.05.006 PMID: 21632283
15. Gustavsson I, Lindell M, Wilander E, Strand A, Gyllensten U. Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol. 2009; 46(2):112-6. doi: 10.1016/j.jcv.2009.06.021 PMID: 19628427
16. Geraets D, van Baars R, Alonso I, Ordi J, Torné A, Melchers W, et al. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge. J Clin Virol. 2013; 57(2):125-9. doi: 10.1016/j.jcv.2013.02.016 PMID: 23518442
17. Guan Y, Gravitt PE, Howard R, Eby YJ, Wang S, Li B, et al. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods. 2013; 189(1):167-71. doi: 10.1016/j.jviromet.2012.11.010 PMID: 23370404
18. Gonzalez P, Cortes B, Quint W, Kreimer AR, Porras C, Rodríguez AC, et al. Evaluation of the FTA Carrier Device for Human Papillomavirus Testing in Developing Countries. J Clin Microbiol. 2012; 50 (12):3870-6. doi: 10.1128/JCM.01698-12 PMID: 22993174
19. Santos CR, Franciscatto LG, Barcellos RB, Almeida SE, Rossetti MLR. Use of FTA elute card impregnated with cervicovaginal sample directly into the amplification reaction increases the detection of human papillomavirus DNA. Braz JMicrobiol. 2012; 43(1):389-92. doi: 10.1590/S1517-838220120001000047 PMID: 24031844
20. Eperon I, Vassilakos P, Navarria I, Menoud P-A, Gauthier A, Pache J-C, et al. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for Human papillomavirus testing. BMC cancer. 2013; 13(1):353.
21. Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi LF, Shen Z, et al. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing. J Med Microbiol. 2012; 61(Pt 11):1538-45. doi: 10.1099/jmm.0.046110-0 PMID: 22899778
22. Kwon MJ, Kyoung HR, Hyosoon P, Hee-Yeon W. "Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection." J Clin Virol. 2014; 59(4):246-922. doi: 10. 1016/j.jcv.2014.01.015 PMID: 24568964
23. Lenselink CH, de Bie RP, van Hamont D, Bakkers JM, Quint WG, Massuger LF, et al. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening J Clin Microbiol. 2009; 47(8):2564-70 doi: 10. 1128/JCM.00285-09 PMID: 19553570